Bafna Pharmaceuticals Ltd Stock Price: Bafna Pharma. Share Price Today

Bafna Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹80.03

Prev. Close

₹80.03

Turnover(Lac.)

₹8.34

Day's High

₹84.03

Day's Low

₹80

52 Week's High

₹96

52 Week's Low

₹69

Book Value

₹35.93

Face Value

₹10

Mkt Cap (₹ Cr.)

198.78

P/E

29.37

EPS

2.66

Divi. Yield

Bafna Pharmaceuticals Ltd Corporate Action

3 Sep 2024

12:00 AM

AGM

Announcement Date: 03 Sep, 2024

23 Jun 2025

12:00 AM

Board Meeting

Agenda : Audited Result

Bafna Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Y/e 31 Mar( In .Cr)	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Equity Capital	23.66	23.66	23.66	23.66
Preference Capital	0	0	0	0
Reserves	57.18	49.8	38.31	33.11
Net Worth	80.84	73.46	61.97	56.77
Minority Interest

Y/e 31 Mar( In .Cr)	Mar-2022	Mar-2021	Mar-2020	Mar-2018
Revenue	85.14	71.21	42.47	77.2
yoy growth (%)	19.54	67.68	-44.98	18.85
Raw materials	-39.28	-36.52	-19.98	-38.28
As % of sales	46.13	51.28	47.05	49.58
Employee costs	-14.5	-11.98	-10.25	-7.47

Y/e 31 Mar( In .Cr)	Mar-2022	Mar-2021	Mar-2020	Mar-2018
Profit before tax	7.3	5.82	-1.87	-14.27
Depreciation	-5.49	-4.47	-3.26	-3.64
Tax paid	0	0	0	-2.17
Working capital	-0.75	16.58	6.23	-27.03
Other operating items

Y/e 31 Mar	Mar-2022	Mar-2021	Mar-2020	Mar-2018
Growth matrix (%)
Revenue growth	19.54	67.68	-44.98	18.85
Op profit growth	11.6	738.01	-124.32	-3.16
EBIT growth	23.33	-468.5	-76.13	-6.25
Net profit growth	-11.59	-123.11	53.2	-10.93

Particulars (Rupees in Crores.)	Mar-2019	Mar-2018	Mar-2017	Mar-2016	Mar-2015
Gross Sales	43.36	47.17	64.96	85.32	97.67
Excise Duty	0	0	0	0	0
Net Sales	43.36	47.17	64.96	85.32	97.67
Other Operating Income	0	0	0	0	41.11
Other Income	1.66	31.33	1.14	1.98	4.9

Bafna Pharmaceuticals Ltd Peer Comparison

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceutical Industries Ltd SUNPHARMA	1,687.6	94.57	4,05,007.74	2,000.46	0.95	7,107.14	101.44
Divis Laboratories Ltd DIVISLAB	6,658	80.01	1,76,747.65	667	0.45	2,536	561.08
Cipla Ltd CIPLA	1,502.4	25.22	1,21,378.29	1,485.4	1.06	4,254.47	397.41
Torrent Pharmaceuticals Ltd TORNTPHARM	3,341.4	59.4	1,13,184.61	474	0.96	2,385	224.33
Dr Reddys Laboratories Ltd DRREDDY	1,301	20.3	1,08,591.61	1,200.7	0.61	5,546.3	345.76

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Bafna Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Whole Time Director

Shanmugam Hemalatha

Non-Exec & Non-Independent Dir

Akilapriya Chandrashekar Raju

Non-Exec. & Independent Dir.

Ravichandran Chitra

Non Executive Director

Upendar Mekala Reddy

Whole-time Director

Vinayak Dinesh Dendukuri

Company Sec. & Compli. Officer

A Mohanachandran

Additional Director

Navin Kumar

Registered Office

Bafna Towers New No 68,

Old No 299 Thambu Chetty St,

Tamil Nadu - 600001

Tel: 91-44-25267517/25270992/4267755

Website: http://www.bafnapharma.com

Email: cs@bafnapharma.com; info@bafnapharma.com

Registrar Office

Subramanian Building,

V Floor, 1 Club House Road,

Chennai - 600 002

Tel: 91-044-28460390 (5 L

Website: www.cameoindia.com

Email: cameo@cameoindia.com

Summary

Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing p...
Read More

Reports by Bafna Pharmaceuticals Ltd

Company FAQs

What is the Bafna Pharmaceuticals Ltd share price today?

The Bafna Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹84.03 today.

What is the Market Cap of Bafna Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bafna Pharmaceuticals Ltd is ₹198.78 Cr. as of 30 Jun ‘25

What is the PE and PB ratio of Bafna Pharmaceuticals Ltd?

The PE and PB ratios of Bafna Pharmaceuticals Ltd is 29.37 and 2.18 as of 30 Jun ‘25

What is the 52 Week High and Low of Bafna Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Bafna Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Bafna Pharmaceuticals Ltd is ₹69 and ₹96 as of 30 Jun ‘25

What is the CAGR of Bafna Pharmaceuticals Ltd?

Bafna Pharmaceuticals Ltd's CAGR for 5 Years at 29.00%, 3 Years at -12.72%, 1 Year at 1.00%, 6 Month at 0.04%, 3 Month at 4.85% and 1 Month at 5.65%.

What is the shareholding pattern of Bafna Pharmaceuticals Ltd?

The shareholding pattern of Bafna Pharmaceuticals Ltd is as follows:
Promoters - 75.00 %
Institutions - 8.53 %
Public - 16.47 %

Bafna Pharmaceuticals Ltd Share Price Live

Equities

Futures

Option

Bafna Pharmaceuticals Ltd KEY RATIOS

Bafna Pharmaceuticals Ltd Corporate Action

Bafna Pharmaceuticals Ltd NEWS AND UPDATE

Knowledge Center

Demat Account

Trading Account

Bafna Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

Promoter- 75.00%

Non-Promoter- 8.53%

Bafna Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Bafna Pharmaceuticals Ltd Peer Comparison

MORE ABOUT Bafna Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Company FAQs

QUICKLINKS FOR Bafna Pharmaceuticals Ltd

Information

Financials

Results

News

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES